We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$28.3B
AUM Growth
-$930M
Cap. Flow
-$234M
Cap. Flow %
-0.83%
Top 10 Hldgs %
43.26%
Holding
1,183
New
46
Increased
601
Reduced
483
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 41.4%
2 Financials 10.42%
3 Consumer Discretionary 7.12%
4 Healthcare 4.51%
5 Industrials 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNX icon
451
Crinetics Pharmaceuticals
CRNX
$8.87B
$4.15M 0.01%
81,257
-16,193
-17% -$906K
UAL icon
452
United Airlines
UAL
$42.1B
$4.12M 0.01%
42,466
-1,191
-3% -$101K
AVB icon
453
AvalonBay Communities
AVB
$26.8B
$4.11M 0.01%
18,693
-1,498
-7% -$338K
IOVA icon
454
Iovance Biotherapeutics
IOVA
$1.88B
$4.1M 0.01%
554,141
-98,825
-15% -$916K
IRM icon
455
Iron Mountain
IRM
$36.5B
$4.06M 0.01%
38,608
-3,087
-7% -$363K
RXRX icon
456
Recursion Pharmaceuticals
RXRX
$1.66B
$4.03M 0.01%
595,472
-80,319
-12% -$540K
IQV icon
457
IQVIA
IQV
$38.3B
$4.02M 0.01%
20,466
+1,916
+10% +$404K
AUB icon
458
Atlantic Union Bankshares
AUB
$6.11B
$4M 0.01%
105,509
+10,085
+11% +$400K
UBSI icon
459
United Bankshares
UBSI
$6.7B
$3.98M 0.01%
105,960
-6,206
-6% -$244K
KR icon
460
Kroger
KR
$35.9B
$3.95M 0.01%
64,543
+5,617
+10% +$330K
DYN icon
461
Dyne Therapeutics
DYN
$4.74B
$3.95M 0.01%
167,482
+2,520
+2% +$74.5K
AME icon
462
Ametek
AME
$55.9B
$3.89M 0.01%
21,601
+2,187
+11% +$398K
AIZ icon
463
Assurant
AIZ
$14B
$3.86M 0.01%
18,095
+536
+3% +$112K
CLDX icon
464
Celldex Therapeutics
CLDX
$2.98B
$3.85M 0.01%
152,454
+61,464
+68% +$1.67M
RSG icon
465
Republic Services
RSG
$64.7B
$3.83M 0.01%
19,018
+1,901
+11% +$394K
RMD icon
466
ResMed
RMD
$31.3B
$3.81M 0.01%
16,650
+693
+4% +$167K
KMB icon
467
Kimberly-Clark
KMB
$37B
$3.79M 0.01%
28,943
+2,946
+11% +$402K
F icon
468
Ford
F
$59.5B
$3.77M 0.01%
380,896
+59,452
+18% +$634K
MTH icon
469
Meritage Homes
MTH
$4.73B
$3.76M 0.01%
48,932
+16,524
+51% +$1.51M
CW icon
470
Curtiss-Wright
CW
$27.4B
$3.76M 0.01%
10,582
+335
+3% +$121K
CUBI icon
471
Customers Bancorp
CUBI
$2.7B
$3.71M 0.01%
76,240
-27,766
-27% -$1.4M
VERA icon
472
Vera Therapeutics
VERA
$2.3B
$3.71M 0.01%
87,686
+8,741
+11% +$387K
FIBK icon
473
First Interstate BancSystem
FIBK
$3.71B
$3.7M 0.01%
113,859
-14,618
-11% -$475K
PTGX icon
474
Protagonist Therapeutics
PTGX
$8.69B
$3.69M 0.01%
95,467
+5,591
+6% +$244K
NEM icon
475
Newmont
NEM
$99.4B
$3.68M 0.01%
98,818
+10,251
+12% +$467K

Similar funds

Rafferty Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Rafferty Asset Management held 1,183 positions worth $28.3B, down 3.2% from $29.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rafferty Asset Management's Q4 2024 filing shows 46 new, 601 increased, 483 reduced and 43 closed positions. Its largest new stake was Apollo Global Management: 157,705 shares worth $26M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 45% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Rafferty Asset Management's largest Q4 2024 buy was Apollo Global Management: 157,705 shares worth $26M.
  • Rafferty Asset Management added most to Tesla in Q4 2024, an estimated $338M increase.
  • Rafferty Asset Management's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $495M.
  • Rafferty Asset Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $9.52M.
  • Rafferty Asset Management's ten largest holdings make up 43% of its $28.3B portfolio in Q4 2024.
  • Rafferty Asset Management opened 46 new positions and closed 43 in Q4 2024.
  • Rafferty Asset Management's portfolio value fell 3.2% quarter-over-quarter to $28.3B.

Based on Rafferty Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.